TLR3 binding agents

Details for Australian Patent Application No. 2010270163 (hide)

Owner Innate Pharma

Inventors Gauthier, Laurent; Massacrier, Catherine; Morel, Yannis; Paturel, Carine

Agent Davies Collison Cave

Pub. Number AU-A-2010270163

PCT Pub. Number WO2011/004028

Priority 61/224,548 10.07.09 US

Filing date 9 July 2010

Wipo publication date 13 January 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/004028 Priority application(s): WO2011/004028

24 May 2012 Alteration of Name

  The name of the applicant has been altered to Innate Pharma, S.A.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010270175-Particle separation tank

2010270153-Substituted pyrrolidinone as inhibitors of hepatitis C NS5B polymerase, the pharmaceutical composition thereof and their therapeutic use